Armen Shanafelt

Insider Reports History

Entity
Individual
Location
C/O Lilly Ventures Fund I, Llc, 115 W. Washington Street,Ste 1680 South, Indianapolis, IN
Signature
/s/ Jessica Fees, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Armen Shanafelt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aeglea BioTherapeutics, Inc. Director Director Stock Option (right to buy) 43K Jun 7, 2022 Direct
Surface Oncology, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 24K Jun 8, 2022 Direct

Insider Reports Filed by Armen Shanafelt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SURF Surface Oncology, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director, 10%+ Owner
AGLE Aeglea BioTherapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
AGLE Aeglea BioTherapeutics, Inc. Dec 9, 2021 3 $550K 4 Dec 13, 2021 Director
SURF Surface Oncology, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director, 10%+ Owner
AGLE Aeglea BioTherapeutics, Inc. Jun 8, 2021 1 $0 4 Jun 9, 2021 Director